Edible Garden Appoints Board Member Matthew McConnell as Executive Vice President, Strategic Partnerships
Globenewswire· 2026-01-09 12:30
BELVIDERE, NJ, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that Matthew McConnell, a member of the Company's Board of Directors, has joined Edible Garden's senior leadership team full time as Executive Vice President Strategic Partnerships, effective immediately. In this role, Mr. McConnell will ...
AMC Robotics Showcases Kyro™ at CES 2026, Embodying the "ChatGPT Moment for Physical AI"
Globenewswire· 2026-01-09 12:30
LAS VEGAS, Jan. 09, 2026 (GLOBE NEWSWIRE) -- AMC Robotics Corporation (Nasdaq: AMCI) ("AMC Robotics" or the "Company"), a leading AI-driven robotics solutions company, today announced its participation at CES® 2026. The Company demonstrated its latest artificial intelligence–powered technologies, headlined by Kyro™, its proprietary quadruped robotic platform. The demonstration comes at a pivotal time for the industry. During his CES 2026 keynote, NVIDIA CEO Jensen Huang declared that "the ChatGPT moment for ...
Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies
Globenewswire· 2026-01-09 12:30
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic malformations (microcystic LMs) remains on track, with topline results anticipated in March 2026; pending positive results, an NDA submission is planned for the second half of 2026 Accelerating U.S. launch readiness for QTORIN™ rapamycin for microcystic LMs which has the potential to become the first FDA-approved therapy and a first-line, standard-of-care treatment for this serious, lifelong dis ...
Indonesia Energy Moves Forward With Two New Wells at Kruh Block, Where Pre-Drilling Operations Have Commenced
Globenewswire· 2026-01-09 12:30
Company to present at upcoming DealFlow Discovery Conference on January 28 JAKARTA, INDONESIA AND DANVILLE, CA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Indonesia Energy Corporation (NYSE American: INDO) ("IEC"), an oil and gas exploration and production company focused on Indonesia, today announced pre-drilling progress on its planned next two (2) wells at IEC's Kruh Block. IEC remains on target to commence drilling at the first of these new wells before the end of this first quarter of 2026. The wells are expect ...
uniQure Announces Type A Meeting Scheduled with FDA
Globenewswire· 2026-01-09 12:05
LEXINGTON, Mass. and AMSTERDAM, Jan. 09, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced a Type A meeting with the U.S. Food and Drug Administration (FDA) has been scheduled to discuss the Biologics License Application (BLA) data package to support accelerated approval of AMT-130, the Company’s investigational gene therapy for the treatment of Huntington’s disease. “We look forward ...
La Rosa Holdings Corp. Announces Closing of Initial Funding Under $250 Million Note Facility as Part of $1.25 Billion AI Infrastructure Program
Globenewswire· 2026-01-09 12:05
Celebration, FL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today announced an initial closing of an $11,000,000 note under its previously announced $250 million private placement convertible note facility (the “Note Facility”). The Company’s total available financing capacity, including the initial closing, is $1.25 billion when combined with its existing $1 billion equity purchase facility. La Rosa will deplo ...
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation
Globenewswire· 2026-01-09 12:05
HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) today announced that it has entered into a series of share purchase agreements with several investors. Ping An Biomedical Co., Ltd. has entered into a series of share purchase agreements from several investors: Yao Jinbo, Chairman and CEO of 58 Group Inc.; Wang Donghui, Founder and Managing Partner of Amiba Capital Co., Ltd; and Li Daxue, Chairman and CEO of Magcloud Group Co., ...
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco
Globenewswire· 2026-01-09 12:00
BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that Chief Executive Officer Ivor Elrifi will deliver a corporate presentation at the 9th Annual Neuroscience Innovation Forum, organized by Sachs Associates. The presentation is scheduled for 2:00 PM PT on January 11, 2026, at the Marines' Memorial Club in San Francisco, Californi ...
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
Globenewswire· 2026-01-09 12:00
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency’s review of Anaphylm NDA application is ongoing and no final FDA decision has been madeProgresses global regulatory expansion activities in Canada, Europe, and the United Kingdom for AnaphylmUnaudited cash and cash equivalents of approximately $120 million as of December 31, 2025 WARREN, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Aquestiv ...
Aurora Mobile Partners with Xiaoe to Enhance Interaction Efficiency and Support Sustainable Growth in Private Domain Ecosystems
Globenewswire· 2026-01-09 12:00
SHENZHEN, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that it has entered into a strategic partnership with Xiaoe Inc. (“Xiaoe”) to integrate its intelligent push notification solution, JPush, into Xiaoe’s flagship private domain SaaS platform. When operating private domains, a platform’s value lies not only in providing operational tools b ...